Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This project was undertaken by Qilu Hospital of Shandong University and other well-known hospitals in China. In order to report the alteration of Different Immune Parameters in ITP Patients Receiving Eltrombopag Treatment.
Epistemonikos ID: 1ad37af353f704ebf4e8063eb1878711c17f654d
First added on: May 11, 2024